BOLD Boundless Bio, Inc. - Common Stock
$2.92
Price · Aug 19, 2026
Fundamentals as of Aug 7, 2026
52W Range
$1–$3
97% of range
Analyst Rating
HOLD
6 analysts
Price Target
$4
+37% upside
P/E (TTM)
-1.1
ROE
-46.7%
Net Profit Margin
—
About Boundless Bio, Inc. - Common Stock Company overview from Wikipedia
BOLD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.92
Market Cap
$65M
P/E (TTM)
-1.1
EPS (TTM)
$-2.60
Revenue (TTM)
—
Div Yield
—
ROE
-46.7%
Debt/Equity
—
52W Range
$1 – $3
BOLD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-2.60
2023-12-31
→
2025-12-31
Free Cash Flow
$-47M
2024-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BOLD
Peer Median
P/E (TTM)
-1.1
—
P/B
0.7
1.6
Price / FCF
-1.4
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BOLD
Peer Median
ROA
-32.0%
-64.3%
ROE
-46.7%
-102.1%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BOLD
Peer Median
Current Ratio
8.7
4.8
Quick Ratio
8.6
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BOLD
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BOLD
Peer Median
BOLD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
SELL
6 analysts
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 3 50.0%
- Sell 1 16.7%
- Strong Sell 2 33.3%
12-Month Price Target
1 analysts · 2026-08-19
Low
$4.00
High
$4.00
Median target
$4.00
+37.2%
Mean target
$4.00
+37.2%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.07%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-1.06 | $-0.59 | -0.47% |
| March 31, 2026 | $-0.60 | $-0.59 | -0.01% |
| Dec. 31, 2025 | $-0.58 | $-0.53 | -0.05% |
| Sept. 30, 2025 | $-0.62 | $-0.59 | -0.03% |
| June 30, 2025 | $-0.70 | $-0.66 | -0.04% |
| March 31, 2025 | $-0.71 | $-0.75 | 0.04% |
| Dec. 31, 2024 | $-0.74 | $-0.78 | 0.04% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| XBIT | — | -1.6 | — | — | — | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $45M | $55M | $43M | |
| SG&A Expense | $19M | $18M | $12M | |
| Operating Expenses | $64M | $73M | $55M | |
| Operating Income | $-64M | $-73M | $-55M | |
| Interest Income | $5M | $8M | $5M | |
| Other Non-op | $-2.0K | $12.0K | $80.0K | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-58M | $-65M | $-49M | |
| EPS (Basic) | $-2.60 | $-3.85 | $-40.65 | |
| EPS (Diluted) | $-2.60 | $-3.85 | $-40.65 | |
| Shares (Basic) | 22,360,000 | 16,984,000 | 1,216,000 | |
| Shares (Diluted) | 22,360,000 | 16,984,000 | 1,216,000 | |
| EBITDA | $-62M | $-72M | · |
Balance Sheet 19
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $18M | $27M | $24M | |
| Short-term Investments | $90M | $126M | $97M | |
| Prepaid Expense | $2M | $2M | $3M | |
| Current Assets | $110M | $154M | $124M | |
| PP&E (Net) | $3M | $4M | $3M | |
| PP&E (Gross) | $8M | $8M | $5M | |
| Accum. Depreciation | $5M | $4M | $3M | |
| Total Assets | $157M | $206M | $130M | |
| Accounts Payable | $1M | $1M | $2M | |
| Current Liabilities | $13M | $8M | $9M | |
| Capital Leases | $46M | $48M | · | |
| Total Liabilities | $58M | $56M | $9M | |
| Common Stock | $2.0K | $2.0K | $0 | |
| Paid-in Capital | $358M | $352M | $9M | |
| Retained Earnings | $-260M | $-201M | $-136M | |
| AOCI | $64.0K | $121.0K | $40.0K | |
| Stockholders' Equity | $99M | $151M | $-127M | |
| Liabilities + Equity | $157M | $206M | $130M | |
| Shares Outstanding | 22,407,000 | 22,300,000 | 1,248 |
Cash Flow 10
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $1M | $1M | $957.0K | |
| Stock-based Comp | $6M | $8M | $3M | |
| Deferred Tax | $0 | · | · | |
| Other Non-cash | $4M | $-4M | · | |
| Operating Cash Flow | $-47M | $-61M | $-47M | |
| CapEx | $546.0K | $3M | $633.0K | |
| Investing Cash Flow | $38M | $-26M | $-38M | |
| Financing Cash Flow | $141.0K | $90M | $98M | |
| Net Change in Cash | $-9M | $3M | $13M | |
| Free Cash Flow | $-47M | $-63M | · |
Profitability 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -32.0% | -38.9% | · | |
| ROE | -46.7% | -554.9% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 8.7 | 19.0 | · | |
| Quick Ratio | 8.6 | 18.7 | · |
Valuation (TTM) 8
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-58M | $-65M | · | |
| Market Cap | $27M | $64.7K | · | |
| P/E | -0.5 | -0.8 | · | |
| P/B | 0.3 | 0.0 | · | |
| P / Tangible Book | 0.3 | 0.0 | · | |
| P / Cash Flow | -0.6 | -0.0 | · | |
| P / FCF | -0.6 | -0.0 | · | |
| Earnings Yield | -216.7% | -132.8% | · |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $10M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | $13M | $10M | |
| SG&A Expense | $10M | $5M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | |
| Operating Expenses | $24M | $14M | $14M | $15M | $17M | $17M | $18M | $19M | $19M | $17M | $14M | |
| Operating Income | $-24M | $-14M | $-14M | $-15M | $-17M | $-17M | $-18M | $-19M | $-19M | $-17M | $-14M | |
| Interest Income | $690.0K | $920.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | |
| Other Non-op | $1.0K | · | $0 | $0 | $0 | $-2.0K | $-85.0K | $32.0K | $33.0K | $32.0K | $64.0K | |
| Net Income | $-24M | $-14M | $-13M | $-14M | $-16M | $-16M | $-16M | $-17M | $-17M | $-15M | $-12M | |
| EPS (Basic) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| EPS (Diluted) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| Shares (Basic) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| Shares (Diluted) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| EBITDA | $-24M | $-14M | · | $-15M | $-17M | $-17M | · | $-19M | $-19M | $-17M | · |
Balance Sheet 19
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $17M | $18M | $15M | $15M | $15M | $27M | $40M | $31M | $25M | $24M | |
| Short-term Investments | $52M | $75M | $90M | $103M | $112M | $123M | $126M | $127M | $148M | $80M | $97M | |
| Prepaid Expense | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $4M | $7M | $3M | |
| Current Assets | $74M | $95M | $110M | $120M | $130M | $140M | $154M | $170M | $183M | $112M | $124M | |
| PP&E (Net) | $97.0K | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $2M | $3M | |
| PP&E (Gross) | $4M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $5M | $5M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Total Assets | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $2M | $1M | $1M | $3M | $2M | $3M | $2M | |
| Current Liabilities | $8M | $10M | $13M | $12M | $9M | $6M | $8M | $10M | $9M | $11M | $9M | |
| Capital Leases | $0 | $45M | $46M | $47M | $48M | $48M | $48M | · | · | · | · | |
| Total Liabilities | $8M | $55M | $58M | $59M | $57M | $55M | $56M | · | · | · | $9M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0 | $0 | |
| Paid-in Capital | $363M | $360M | $358M | $357M | $356M | $354M | $352M | $350M | $348M | $10M | $9M | |
| Retained Earnings | $-297M | $-273M | $-260M | $-247M | $-233M | $-217M | $-201M | $-185M | $-169M | $-152M | $-136M | |
| AOCI | $-32.0K | $-23.0K | $64.0K | $50.0K | $-4.0K | $32.0K | $121.0K | $236.0K | $-64.0K | $-21.0K | $40.0K | |
| Stockholders' Equity | $66M | $86M | $99M | $110M | $123M | $137M | $151M | $165M | $179M | $-141M | $-127M | |
| Liabilities + Equity | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Shares Outstanding | 22,475,000 | 22,407,000 | 22,407,000 | 22,386,000 | 22,386,000 | 22,300,000 | 22,300,000 | 22,254,465 | 22,254,102 | 1,262,638 | 1,248 |
Cash Flow 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $284.0K | $307.0K | $310.0K | $317.0K | $317.0K | $296.0K | $262.0K | $265.0K | $263.0K | $247.0K | |
| Stock-based Comp | $3M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $911.0K | |
| Other Non-cash | · | $-3M | · | · | · | $-886.0K | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-15M | $-10M | $-10M | $-12M | $-15M | $-16M | $-13M | $-16M | $-16M | $-12M | |
| CapEx | $38.0K | $8.0K | $424.0K | $15.0K | $48.0K | $59.0K | $466.0K | $483.0K | $2M | $83.0K | $268.0K | |
| Investing Cash Flow | $23M | $15M | $13M | $10M | $11M | $3M | $2M | $22M | $-68M | $18M | $16M | |
| Financing Cash Flow | · | · | $24.0K | $0 | · | · | $113.0K | $-13.0K | $91M | $-924.0K | $-1M | |
| Net Change in Cash | $2M | $-385.0K | $3M | $283.0K | $-420.0K | $-11M | $-14M | $9M | $6M | $1M | $3M | |
| Free Cash Flow | · | $-15M | · | · | · | $-15M | · | · | · | $-16M | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.7% | -8.2% | · | -8.1% | -8.5% | -10.2% | · | -18.9% | -18.0% | -26.4% | · | |
| ROE | -25.1% | -12.2% | · | -10.1% | -10.4% | 686.3% | · | -20.0% | -18.9% | 21.9% | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.5 | 9.9 | · | 10.1 | 14.1 | 22.1 | · | 17.0 | 20.4 | 10.5 | · | |
| Quick Ratio | 9.3 | 9.7 | · | 9.9 | 13.8 | 21.8 | · | 16.7 | 20.0 | 9.9 | · |
Valuation (TTM) 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-67M | $-59M | · | $-62M | $-65M | $-65M | · | $-62M | $-58M | $-53M | · | |
| Market Cap | $56M | $25M | · | $28M | $23M | $34M | · | $77M | $86M | $18M | · | |
| P/E | -0.8 | -0.4 | · | -0.4 | -0.3 | -0.1 | · | -0.1 | -0.1 | -0.3 | · | |
| P/B | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | -0.1 | · | |
| P / Tangible Book | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | · | · | |
| P / Cash Flow | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| P / FCF | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| Earnings Yield | -119.2% | -239.1% | · | -225.2% | -289.1% | -959.6% | · | -705.8% | -879.3% | -302.9% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Net Income | $-58M | $-65M | $-49M |
| Diluted EPS | $-2.60 | $-3.85 | $-40.65 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Current Ratio | 8.7 | 19.0 | — |
| Quick Ratio | 8.6 | 18.7 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Free Cash Flow | $-47M | $-63M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 45 filers · $37.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 16 (+12 vs prior Q) | 7 (+1 vs prior Q) | 8 (+2 vs prior Q) | 10 (+2 vs prior Q) | +8.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| ARCH Venture Management, LLC | $6,735,238 | 2,694,095 | 17.91% | Shares |
| TANG CAPITAL MANAGEMENT LLC | $6,399,688 | 2,559,875 | 17.02% | Shares |
| ADAR1 Capital Management, LLC | $4,920,540 | 1,968,216 | 13.08% | Shares |
| Nextech Invest Ltd. | $3,561,400 | 1,228,069 | 9.47% | Shares |
| FMR LLC | $3,332,450 | 1,332,980 | 8.86% | Shares |
| Cormorant Asset Management, LP | $2,500,000 | 1,000,000 | 6.65% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,537,308 | 614,923 | 4.09% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $1,390,583 | 556,233 | 3.70% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,196,598 | 478,639 | 3.18% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,178,925 | 471,570 | 3.13% | Shares |
| Alyeska Investment Group, L.P. | $750,000 | 300,000 | 1.99% | Shares |
| Affinity Asset Advisors, LLC | $625,000 | 250,000 | 1.66% | Shares |
| RBF Capital, LLC | $500,000 | 200,000 | 1.33% | Shares |
| Ensign Peak Advisors, Inc | $399,588 | 159,835 | 1.06% | Shares |
| Stonepine Capital Management, LLC | $386,488 | 154,595 | 1.03% | Shares |
| CITADEL ADVISORS LLC | $362,623 | 145,049 | 0.96% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $320,000 | 128,000 | 0.85% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $240,132 | 96,053 | 0.64% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $209,995 | 83,998 | 0.56% | Shares |
| Rangeley Capital, LLC | $185,000 | 74,000 | 0.49% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $162,840 | 65,136 | 0.43% | Shares |
| SUPERSTRING CAPITAL MANAGEMENT LP | $138,390 | 55,356 | 0.37% | Shares |
| JANE STREET GROUP, LLC | $114,675 | 45,870 | 0.30% | Shares |
| NORTHERN TRUST CORP | $87,060 | 34,824 | 0.23% | Shares |
| XTX Topco Ltd | $83,403 | 33,361 | 0.22% | Shares |
| Nuveen Asset Management, LLC | $62,417 | 21,523 | 0.17% | Shares |
| Qube Research & Technologies Ltd | $50,518 | 20,207 | 0.13% | Shares |
| China Universal Asset Management Co., Ltd. | $42,250 | 16,900 | 0.11% | Shares |
| STATE STREET CORP | $39,905 | 15,962 | 0.11% | Shares |
| MORGAN STANLEY | $32,500 | 13,000 | 0.09% | Shares |
| Caitong International Asset Management Co., Ltd | $26,108 | 10,443 | 0.07% | Shares |
| Pure Financial Advisors, LLC | $25,250 | 10,100 | 0.07% | Shares |
| BlackRock, Inc. | $10,223 | 4,089 | 0.03% | Shares |
| Tower Research Capital LLC (TRC) | $870 | 348 | 0.00% | Shares |
| VANGUARD GROUP INC | $515 | 429 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $440 | 176 | 0.00% | Shares |
| ACADIAN ASSET MANAGEMENT LLC | $365 | 146,757 | 0.00% | Shares |
| HRT FINANCIAL LP | $290 | 116,288 | 0.00% | Shares |
| GSA CAPITAL PARTNERS LLP | $181 | 72,353 | 0.00% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $125 | 50 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $25 | 10 | 0.00% | Shares |
| CWM, LLC | $9 | 8 | 0.00% | Shares |
| Financial Management Professionals, Inc. | $5 | 2 | 0.00% | Shares |
| UBS Group AG | $5 | 2 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $5 | 2 | 0.00% | Shares |
Company insiders 14 insiders · 8 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Zachary Hornby | President & CEO | Jan. 23, 2026 A | — | 0 | 0 | $0 |
| Jami Rubin | Chief Financial Officer | Aug. 19, 2024 A | — | 0 | 0 | $0 |
| Robert Doebele | Chief Medical Officer | Jan. 23, 2026 A | — | 0 | 0 | $0 |
| Jessica Oien | Chief Legal Officer and Corporate Secretary | Jan. 23, 2026 A | — | 0 | 0 | $0 |
| Christian Hassig | Chief Scientific Officer | Jan. 23, 2026 A | — | 0 | 0 | $0 |
| David A Hinkle | Senior VP, Finance, Controller and Treasurer | Jan. 23, 2026 A | — | 0 | 0 | $0 |
| Klaus W. Wagner | Chief Medical Officer | Aug. 19, 2024 A | — | 0 | 0 | $0 |
| Neil Abdollahian | Chief Business Officer | Aug. 19, 2024 A | — | 0 | 0 | $0 |
| James Christensen | Director | June 15, 2026 A | — | 0 | 0 | $0 |
| Nancy Whiting | Director | June 15, 2026 A | — | 0 | 0 | $0 |
| Jennifer Lew | Director | June 15, 2026 A | — | 0 | 0 | $0 |
| Jonathan E Lim | Director | June 15, 2026 A | 550,915 | 0 | 0 | $0 |
| Christine Brennan | Director | June 23, 2025 A | — | 0 | 0 | $0 |
| Kristina Burow | Director | June 23, 2025 A | 1,181,766 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee, Kristina Burow, Steven Gillis | Oct. 29, 2024 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.